Resistance May Be Pharmacy's Best Bet In Meningitis Probe

Law360, New York (October 24, 2012, 10:41 PM EDT) -- Counsel for the New England Compounding Center has criticized and even directed blame toward regulators in the wake of a deadly meningitis outbreak, a tactic attorneys say would make little sense for a more established drugmaker but could offer the best strategy for a pharmacy likely on the verge of insolvency.

The NECC's attorney Paul Cirel of Collora LLP has now issued statements in consecutive weeks chastising government regulators. Last week, following a raid of the NECC's Framingham, Mass., facility by the U.S. Food and Drug...
To view the full article, register now.